Antagonists of Both D1 and D2 Mammalian Dopamine Receptors Block the Effects of Dopamine on Helix aspersa Neurons

  • Kim, Young-Kee (Department of Agricultural Chemistry, Chungbuk National University) ;
  • Woodruff, Michael L. (Department of Anatomy and Cell Biology, UCLA School of Medicine)
  • Received : 1994.10.28
  • Published : 1995.05.31

Abstract

Dopamine mediates inhibitory responses in Helix aspersa neurons from the right parietal lobe ("F-lobe") of the circumoesophageal ganglia. The effects appeared as a dose-dependent hyperpolarization of the plasma membrane and a decrease in the occurrence of spontaneous action potentials. The average hyperpolarization with 5 ${\mu}m$ dopamine was -12 mV (${\pm}1.5$mV, S.D., n=12). Dopamine also modulated the currents 'responsible for shaping the action potentials in these neurons. When dopamine was added and action potentials were triggered by an injection of current, the initial depolarization was slowed, the amplitude and the duration of action potentials were decreased, and the after-hyperpolarization was more pronounced. The amplitude and the duration of action potential were reduced about 15 mV and about 13% by 5 ${\mu}m$ dopamine, respectively. The effects of dopamine on the resting membrane potentials and the action potentials of Helix neurons were dose-dependent in the concentration range 0.1 ${\mu}m$ to 50 ${\mu}m$. In order to show 1) that the effects of dopamine were mediated by dopamine receptors rather than by direct action on ionic channels and 2) which type of dopamine receptor might be responsible for the various effects, we assayed the ability of mammalian dopamine receptor antagonists, SCH-23390 (antagonist of D1 receptor) and spiperone (antagonist of D2 receptor), to block the dopamine-dependent changes. The D1 and D2 antagonists partially inhibited the dopamine-dependent hyperpolarization and the decrease in action potential amplitude. They both completely blocked the decrease in action potential duration and the increase in action potential after-hyperpolarization. The dopamine-induced slowdown of the depolarization in the initial phase of the action potentials was less effected by SCH-23390 and spiperone. From the results we suggest 1) that Helix F-lobe neurons may have a single type of dopamine receptor that binds both SCH-23390 and spiperone and 2) that the dopamine receptor of Helix F-lobe neurons may be homologous with and primitive to the family of mammalian dopamine receptors.

Keywords

References

  1. J. Physiol. v.225 Ascher, P. https://doi.org/10.1113/jphysiol.1972.sp009933
  2. Nature v.336 Bunzow, J.R.;Van Tol, H.H.M.;Grandy, D.K.;Albert, P.;Salon, J.;Christie, M.;Machida, C.A.;Neve, K.A.;Civelli, O. https://doi.org/10.1038/336783a0
  3. Eur. J. Pharmacol. v.207 Civelli, O.;Bunzow, J.R.;Grandy, D.K.;Zhiu, Q.;Van Tol, H.H.M. https://doi.org/10.1016/0922-4106(91)90001-X
  4. Nature v.347 Dearry, A.;Gingrich, J.A.;Falardeau, P.;Fremeau, R.T. Jr.;Bates, M.D.;Caron, M.G. https://doi.org/10.1038/347072a0
  5. J. Neurochem. v.48 Fischer, S.K.;Agranoff, B.W. https://doi.org/10.1111/j.1471-4159.1987.tb05618.x
  6. Life Sci. v.33 Gospe, S.M.
  7. Neuron v.1 Harris-Warrick, R.M.;Hammond, C.;Paupardin-Tritsch, D.;Homburger, V.;Rouot, B.;Bockaert, J.;Gerschenfeld, H.M. https://doi.org/10.1016/0896-6273(88)90206-1
  8. Nature v.277 Kebablian, J.W.;Calne, D https://doi.org/10.1038/277093a0
  9. Comp. Biochem. Physiol. v.50A Kerkut, G.A.;Lambert, J.D.C.;Gayton, R.J.;Loker, J.E.;Walker, R.J.
  10. Mol. Cell. Endocrinol. v.54 Nizmik, H.B. https://doi.org/10.1016/0303-7207(87)90134-1
  11. J. Neurosci. v.5 Paupardin-Tritsch, D.;Colombaioni, L.;Deterre, P.;Gerschenfeld, H.M. https://doi.org/10.1523/JNEUROSCI.05-09-02522.1985
  12. Trends Pharmacol. Sci. v.13 Sibley, D.R.;Monsma, F.J. Jr. https://doi.org/10.1016/0165-6147(92)90025-2
  13. Nature v.347 Sunahara, R.K.;Niznik, H.B.;Weiner, D.M.;Stormann, T.M.;Brann, M.R.;Kennedy, J.L.;Gelernter, J.E.;Rozmahel, R.;Yang, Y.;Israel, Y.;Seeman, P.;O'Down, B.F. https://doi.org/10.1038/347080a0
  14. Comp. Biochem. Physiol. v.101C Tiwari, S.K.;Woodruff, M.L.
  15. Comp. Biochem. Physiol. v.83C Vlieger, T.H.;Lodder, J.C.;Stoof, J.C.;Werkman, T.R.
  16. Nature v.347 Zhou, Q.Y.;Grandy, D.K.;Thambi, L.;Kushner, J.A.;Van Tol, H.H.M.;Cone, R.;Pribnow, D.;Salon, J.;Bunzow, J.R.;Civelli, O. https://doi.org/10.1038/347076a0